Professional Bio
Steven H. Bernstein, MD, is Professor of Medicine and Co-Director of the
Lymphoma Biology Program at the James P. Wilmot Cancer Center, University of Rochester Medical Center, New York, NY. He earned a medical degree from the New York University School of Medicine. Subsequently, he was a clinical fellow in hematology and oncology at Beth Israel Hospital in Boston, Massachusetts, and a research fellow in medicine in the Laboratory of Clinical Pharmacology at Dana-Farber Cancer Institute in Boston.
Dr. Bernstein is a member of the American Society of Clinical Oncology, American Society for Blood and Marrow Transplantation, American Association for Cancer Research, American Society of Hematology, and American College of Physicians. Dr. Bernstein is also a member of the Lymphoma Working Group, Lymphoma Core Committee, and Lymphoma Biology Committee of the Southwest Oncology Group (SWOG). He has published numerous articles in peer-reviewed journals and has
authored numerous abstracts and four book chapters. Dr. Bernstein has been awarded numerous grants to study hematologic malignancies and has been the principal investigator for many clinical protocols in lymphomas and leukemias.
2005 Apr 1
Ray DM, Akbiyik F, Bernstein SH, Phipps RP. "CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanism." Journal of immunology (Baltimore, Md. : 1950). 2005 Apr 1; 174(7):4060-9. |
2005 Mar 1
Ryan EP, Pollock SJ, Pollack SJ, Murant TI, Bernstein SH, Felgar RE, Phipps RP. "Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production." Journal of immunology (Baltimore, Md. : 1950). 2005 Mar 1; 174(5):2619-26. |
2005 Feb 1
Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, Bernstein ZP, McCarthy P, Alam A, Hernandez-Ilizaliturri F, Skipper M, Brown K, Chanan-Khan A, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez A, Bernstein SH. "Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma." Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2005 Feb 1; 23(4):694-704. |
2005
Lou, Q; Conway, Jr TF; Egilmez, NK; Bernstein, SH; Loyall, JL; Kelleher, Jr RJ; Bankert, RB. "B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells". Clinical Immunology. 2005; ahead of print. |
2005
Ryan, EP; Pollack, SJ; Murant, TI; Bernstein, SH; Felgar, RE; Phipps RP. "Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production." Journal of Immunology. 2005; 5: 2619-26. |
